NCT01915342

Brief Summary

The overall aim of the proposed study is to determine optimal parameter of focal muscle vibration for improving spasticity and identify neurophysiological mechanism in healthy subjects. In investigation I-1, subjects will undergo focal muscle vibration with 40, 80, 120 Hz frequency at the medial gastrocnemius muscles (mGCM). As a surrogate maker of spasticity, H-reflex and compound motor action potential (CMAP) of the tibial nerve at mGCM will be recorded pre, during, and post vibration. In investigation I-2, subjects will undergo focal muscle vibration with 0.1, 0.3, 0.5 mm amplitude at mGCM. H-reflex and CMAP of the tibial nerve at mGCM will be recorded pre, during, and post vibration. In investigation II, subjects will undergo focal muscle vibration with predetermined parameters by the investigation I at mGCM. H-reflex and CMAP of the tibial nerve and motor evoked potential at mGCM will be recorded pre, during, and post vibration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2013

Completed
4 days until next milestone

Study Start

First participant enrolled

August 1, 2013

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 2, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

October 10, 2014

Status Verified

October 1, 2014

Enrollment Period

7 months

First QC Date

July 28, 2013

Last Update Submit

October 8, 2014

Conditions

Keywords

Monosynaptic reflexH-reflex

Outcome Measures

Primary Outcomes (1)

  • H/M ratio

    The ratio of maximal H-reflex amplitude (mV) to CMAP amplitude (mV) recorded at mGCM

    baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration

Secondary Outcomes (6)

  • H amplitude

    baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration

  • M amplitude

    baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration

  • motor evoked potential (MEP) amplitude

    baseline, 10 minutes during vibration, and 5 minutes after vibration

  • Resting motor threshold (RMT)

    baseline, 10 minutes during vibration, and 5 minutes after vibration

  • Short interval intracortical inhibition

    baseline, 10 minutes during vibration, and 5 minutes after vibration

  • +1 more secondary outcomes

Study Arms (1)

Focal muscle vibration

EXPERIMENTAL

Focal muscular vibration will be applied at mGCM of each subject for 10 minutes in each session. Frequency: 40, 80, 120 Hz Amplitude: 0.1, 0.3, 0.5 mm

Device: Focal muscular vibration

Interventions

Focal muscle vibration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteer

You may not qualify if:

  • Unstable medical conditions
  • History of epilepsy
  • History of drug abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110-744, South Korea

Location

MeSH Terms

Conditions

Muscle Spasticity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Rehabilitation Medicine

Study Record Dates

First Submitted

July 28, 2013

First Posted

August 2, 2013

Study Start

August 1, 2013

Primary Completion

March 1, 2014

Study Completion

September 1, 2014

Last Updated

October 10, 2014

Record last verified: 2014-10

Locations